Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved an administrative notice about government funding and NIH operating status from the study page. This is an operational change and does not affect the study details, eligibility criteria, or results planning.SummaryDifference0.4%

- Check34 days agoChange DetectedResults have been posted for the study; the results section and related dates (e.g., Results First Posted) have been added or updated. Primary and secondary outcome measures are now presented.SummaryDifference0.5%

- Check63 days agoChange DetectedUpdated version to v3.2.0 and added a government funding/operating-status notice for the NIH Clinical Center; removed reference to v3.1.0.SummaryDifference4%

- Check70 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.5%

- Check85 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' link/button was removed.SummaryDifference0.3%

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.